AIM: To identify novel or rare rhodopsin gene mutations in patients with autosomal dominant retinitis pigmentosa and description of their clinical phenotype. METHODS: The complete rhodopsin gene was screened for mutations by DNA sequencing in index patients. Mutation specific assays were used for segregation analysis and screening for controls. Eight patients from five families and their relatives were diagnosed with autosomal dominant retinitis pigmentosa (adRP) by means of clinical evaluation. RESULTS: Mutation screening identified five different rhodopsin mutations including three novel mutations: Ser176Phe, Arg314fs16, and Val20Gly and two missense mutations, Pro215Leu and Thr289Pro, that were only reported once in a mutation report. Electrophysiological and psychophysical testings provide evidence of an impaired rod system with additionally affected cone system in subjects from each genotype group. Visual function tended to be less affected in subjects with the Arg314fs16 and Val20Gly mutations than in the Ser176Phe phenotype. In contrast, Pro215Leu and Thr289Pro mutations caused a remarkably severe phenotype. CONCLUSION: The ophthalmic findings support a correlation between disease expression and structural alteration: (1) extracellular/intradiscal Val20Gly and cytoplasmic Arg314fs16 mutation-mild adRP phenotype; (2) Ser176Phe mutation-"mostly type 1" disease; (3) predicted alteration of transmembrane domains TM V and TM VII induced by Pro215Leu and Thr289Pro-severe phenotype. However, variation of phenotype expression in identical genotypes may still be a typical feature of RHO mutations.
AIM: To identify novel or rare rhodopsin gene mutations in patients with autosomal dominant retinitis pigmentosa and description of their clinical phenotype. METHODS: The complete rhodopsin gene was screened for mutations by DNA sequencing in index patients. Mutation specific assays were used for segregation analysis and screening for controls. Eight patients from five families and their relatives were diagnosed with autosomal dominant retinitis pigmentosa (adRP) by means of clinical evaluation. RESULTS: Mutation screening identified five different rhodopsin mutations including three novel mutations: Ser176Phe, Arg314fs16, and Val20Gly and two missense mutations, Pro215Leu and Thr289Pro, that were only reported once in a mutation report. Electrophysiological and psychophysical testings provide evidence of an impaired rod system with additionally affected cone system in subjects from each genotype group. Visual function tended to be less affected in subjects with the Arg314fs16 and Val20Gly mutations than in the Ser176Phe phenotype. In contrast, Pro215Leu and Thr289Pro mutations caused a remarkably severe phenotype. CONCLUSION: The ophthalmic findings support a correlation between disease expression and structural alteration: (1) extracellular/intradiscal Val20Gly and cytoplasmic Arg314fs16 mutation-mild adRP phenotype; (2) Ser176Phe mutation-"mostly type 1" disease; (3) predicted alteration of transmembrane domains TM V and TM VII induced by Pro215Leu and Thr289Pro-severe phenotype. However, variation of phenotype expression in identical genotypes may still be a typical feature of RHO mutations.
Authors: A L Lyness; W Ernst; M P Quinlan; G M Clover; G B Arden; R M Carter; A C Bird; J A Parker Journal: Br J Ophthalmol Date: 1985-05 Impact factor: 4.638
Authors: T Jeffrey Keen; Matthew M Hims; Arthur B McKie; Anthony T Moore; Rob M Doran; David A Mackey; David C Mansfield; Robert F Mueller; Shomi S Bhattacharya; Alan C Bird; Alexander F Markham; Chris F Inglehearn Journal: Eur J Hum Genet Date: 2002-04 Impact factor: 4.246
Authors: T P Dryja; T L McGee; E Reichel; L B Hahn; G S Cowley; D W Yandell; M A Sandberg; E L Berson Journal: Nature Date: 1990-01-25 Impact factor: 49.962
Authors: C H Sung; C M Davenport; J C Hennessey; I H Maumenee; S G Jacobson; J R Heckenlively; R Nowakowski; G Fishman; P Gouras; J Nathans Journal: Proc Natl Acad Sci U S A Date: 1991-08-01 Impact factor: 11.205
Authors: Susan F Murray; Ali Jazayeri; Michael T Matthes; Douglas Yasumura; Haidong Yang; Raechel Peralta; Andy Watt; Sue Freier; Gene Hung; Peter S Adamson; Shuling Guo; Brett P Monia; Matthew M LaVail; Michael L McCaleb Journal: Invest Ophthalmol Vis Sci Date: 2015-10 Impact factor: 4.799
Authors: Joseph Carroll; Rigmor C Baraas; Melissa Wagner-Schuman; Jungtae Rha; Cory A Siebe; Christina Sloan; Diane M Tait; Summer Thompson; Jessica I W Morgan; Jay Neitz; David R Williams; David H Foster; Maureen Neitz Journal: Proc Natl Acad Sci U S A Date: 2009-11-23 Impact factor: 11.205
Authors: D Paul Mallory; Elizabeth Gutierrez; Margaret Pinkevitch; Christie Klinginsmith; William D Comar; Francis J Roushar; Jonathan P Schlebach; Adam W Smith; Beata Jastrzebska Journal: Biochemistry Date: 2018-08-21 Impact factor: 3.162
Authors: Cécilia Maubaret; Maria Kosmaoglou; Sancy Low; Christina F Chakarova; Samuel Bidot; Christel Thauvin-Robinet; Anthony G Robson; Naushin Waseem; Michael E Cheetham; Shomi S Bhattacharya Journal: Mol Vis Date: 2012-03-02 Impact factor: 2.367
Authors: Nina Kobal; Tjaša Krašovec; Maja Šuštar; Marija Volk; Borut Peterlin; Marko Hawlina; Ana Fakin Journal: Int J Mol Sci Date: 2021-02-21 Impact factor: 5.923